ABBY SCHREKENHOFER: Open Payments
NPI 1962166785 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 42 payments from 12 companies in 2025. Trend: 2023 $1,115 · 2024 $402 · 2025 $792
Food & beverage: $712Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $235 |
| Lilly USA, LLC | 11 | $192 |
| ABBVIE INC. | 4 | $72 |
| LEO Pharma Inc. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $36 |
| Incyte Corporation | 1 | $30 |
| GENZYME CORPORATION | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $21 |
Products named: TREMFYA, TALTZ, SKYRIZI, DUPIXENT, ANZUPGO, Rhapsido, OPZELURA, ILUMYA.
Industry payments across AR — which companies pay providers there.
